title: Ectopic Cushing's syndrome in light of modern diagnostic techniques and treatment options.
abstract: Ectopic adrenocorticotropic hormone secretion (EAS) is responsible for approximately 10-15% cases of Cushing's syndrome. EAS is associated with various tumors such as small cell lung cancer and well-differentiated bronchial or gastrointestinal neuroendocrine tumors. Hormonal diagnostics include assessments in basic conditions as well as dynamic tests, such as the high-dose dexamethasone suppression test and corticotrophin releasing hormone (CRH) stimulation test. Treatment selection depends on the type of tumor and its extent. In the case of neuroendocrine tumors, the main treatments are surgery and administration of somatostatin analogs that may be additionally radiolabeled for targeted radiotherapy. The tumor histology and the presence and control of hypercortisolemia and metastases are of major importance in prognosis. In this article we presented the principles of modern hormonal and imaging diagnostics techniques as well as the key issues associated with treatment of ACTH-dependent Cushing's syndrome due to EAS.
authors: Department of Endocrinology and Isotope Therapy, Military Institute of Medicine, Warsaw, Poland.
authors: Przemysław
authors: P
authors: Witek
authors: Outpatient Clinic, Institute of Mother and Child, Warsaw, Poland.
authors: Joanna
authors: J
authors: Witek
authors: Department of Neurosurgery, Military Institute of Medicine, Warsaw, Poland.
authors: Grzegorz
authors: G
authors: Zieliński
authors: Department of Endocrinology and Isotope Therapy, Military Institute of Medicine, Warsaw, Poland.
authors: Zbigniew
authors: Z
authors: Podgajny
authors: Department of Endocrinology and Isotope Therapy, Military Institute of Medicine, Warsaw, Poland.
authors: Grzegorz
authors: G
authors: Kamiński
mesh_terms: D000182:ACTH Syndrome, Ectopic / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D003480:Cushing Syndrome / Q000209:etiology*; D006801:Humans